64 related articles for article (PubMed ID: 2807154)
1. Diagnostic procedure before reoperation in patients with medullary thyroid carcinoma.
Raue F; Winter J; Frank-Raue K; Lorenz D; Herfarth C; Ziegler R
Horm Metab Res Suppl; 1989; 21():31-4. PubMed ID: 2807154
[TBL] [Abstract][Full Text] [Related]
2. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
Meybier H; Schmidt-Gayk H; Buhr H; Raue F
Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
[TBL] [Abstract][Full Text] [Related]
3. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
Bugalho MJ; Santos JR; Sobrinho L
J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
[TBL] [Abstract][Full Text] [Related]
5. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
Gautvik KM
Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
7. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization.
Frank-Raue K; Raue F; Buhr HJ; Baldauf G; Lorenz D; Ziegler R
Thyroid; 1992; 2(2):113-7. PubMed ID: 1525578
[TBL] [Abstract][Full Text] [Related]
8. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
9. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
10. PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
Raue F; Blind E; Grauer A
Henry Ford Hosp Med J; 1992; 40(3-4):296-8. PubMed ID: 1483876
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
12. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
[TBL] [Abstract][Full Text] [Related]
14. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
15. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
[TBL] [Abstract][Full Text] [Related]
16. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer.
Trimboli P; Rossi F; Baldelli R; Laurenti O; Nigri G; Ventura C; Appetecchia M; Attanasio D; Romanelli F; Guidobaldi L; Guarino M; Crescenzi A; Valabrega S
Diagn Cytopathol; 2012 May; 40(5):394-8. PubMed ID: 21563324
[TBL] [Abstract][Full Text] [Related]
17. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.
Bhanot P; Yang J; Schnadig VJ; Logroño R
Diagn Cytopathol; 2007 May; 35(5):285-92. PubMed ID: 17427218
[TBL] [Abstract][Full Text] [Related]
18. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
[TBL] [Abstract][Full Text] [Related]
19. [Diarrhea as initial manifestation of medullary thyroid carcinoma].
Suter WR; Fantin AC; Meyenberger C
Dtsch Med Wochenschr; 1998 Sep; 123(39):1134-8. PubMed ID: 9793016
[TBL] [Abstract][Full Text] [Related]
20. [Medullary thyroid carcinoma. Results of a family screening program].
Kotzerke J; Schober O; Heintz P; Dralle H; Hundeshagen H
Dtsch Med Wochenschr; 1986 Jul; 111(30):1140-3. PubMed ID: 3525082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
